Bupivacaine implant - Innocoll

Next Previous
Drug Profile

Bupivacaine implant - Innocoll

Alternative Names: B-Implant; Bupivacaine HCl collagen-matrix implant - Innocoll; Bupivacaine-collagen bioresorbable implant - Innocoll; CollaRx® Bupivacaine implant; INL-001; INN-LD-01; XaraColl

Latest Information Update: 20 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Innocoll
  • Class Anilides; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Postoperative pain
  • No development reported Pain

Most Recent Events

  • 15 Aug 2017 Innocoll completes a phase II trial for Postoperative pain in USA (NCT03234374)
  • 24 Jul 2017 Innocoll has been acquired by Gurnet point capital
  • 16 Jun 2017 Innocoll initiates enrolment in a phase II/III trial for Postoperative pain in USA (NCT03262688)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top